Received Mar 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Inappropriate Reconstitution Technique/only administered the diluent; Inappropriate Reconstitution Technique/only administered the diluent; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received MMR (Priorix) for prophylaxis. On 11-MAR-2025, the patient received Priorix. On 11-MAR-2025, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: Inappropriate Reconstitution Technique/only administered the diluent) and inappropriate dose of vaccine administered (Verbatim: Inappropriate Reconstitution Technique/only administered the diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-MAR-2025 The pharmacist reported that a patient who was only administered the diluent component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.